| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.9 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |